Home/Medicines/Glucosamine + Chondroitin
All medicines

Glucosamine + Chondroitin

Nutraceutical joint supplement (chondroprotective)
Last reviewed 19 Apr 2026 · PetCare.AI Editorial Team
Species
Dog, Cat
Brands
4 available
Formulations
2

Mechanism of action

Glucosamine provides substrate for glycosaminoglycan synthesis in cartilage matrix; chondroitin sulfate inhibits cartilage-degrading enzymes and supports water retention in cartilage

At a glance

Class
Nutraceutical joint supplement (chondroprotective)
Schedule
OTC
Storage
Store below 25°C, protect from moisture

Dosing

🐕

Dog

Osteoarthritis / Joint health maintenance / Post-surgical joint support
Dose
20–30 mg glucosamine/kg
Route
PO
Frequency
SID (loading dose BID for 4–6 weeks)
Max dose
1500 mg
Duration: Long-term; 4–8 weeks for noticeable effect
🐈

Cat

Osteoarthritis / Joint health
Dose
100–125 mg per cat (glucosamine)
Route
PO
Frequency
SID
Max dose
250 mg
Duration: Long-term

Formulations

💊

Chewable tablet — 1

Strength
500mg glucosamine/400mg chondroitin
Available in India
💊

Powder — 1

Strength
Variable
Available in India

Storage

Store below 25°C, protect from moisture

Safety

Use with caution

  • Shellfish allergy (glucosamine from shellfish sources)
    Use non-shellfish source if concerned
  • Diabetes mellitus
    Glucosamine may affect insulin sensitivity (clinical significance debated)

Adverse effects

Common
Mild GI upset
Soft stools
Serious
None well-documented at therapeutic doses

Monitoring parameters

Lameness scoringJoint mobility assessmentBody weight

Interactions

No documented interactions.

Brands

International

Cosequin
Nutramax
Dasuquin
Nutramax

India

ArthroVet
VetPlus India
Jointsure
Petcare India

FAQs

Frequently asked questions

What is Glucosamine + Chondroitin?
Glucosamine + Chondroitin is a nutraceutical joint supplement (chondroprotective) used in pets. Glucosamine provides substrate for glycosaminoglycan synthesis in cartilage matrix; chondroitin sulfate inhibits cartilage-degrading enzymes and supports water retention in cartilage
What is Glucosamine + Chondroitin used for in pets?
Glucosamine + Chondroitin is used in veterinary medicine for: Osteoarthritis / Joint health maintenance / Post-surgical joint support; Osteoarthritis / Joint health.
What is the Glucosamine + Chondroitin dose for dogs?
For dogs, Glucosamine + Chondroitin is typically dosed as follows — Osteoarthritis / Joint health maintenance / Post-surgical joint support: 20–30 mg glucosamine/kg PO SID (loading dose BID for 4–6 weeks). Always consult your veterinarian for a dose tailored to your pet's weight, age, and condition.
What is the Glucosamine + Chondroitin dose for cats?
For cats, Glucosamine + Chondroitin is typically dosed as follows — Osteoarthritis / Joint health: 100–125 mg per cat (glucosamine) PO SID. Always consult your veterinarian for a dose tailored to your pet's weight, age, and condition.
What are the side effects of Glucosamine + Chondroitin?
Common: Mild GI upset, Soft stools. Serious (call your vet immediately): None well-documented at therapeutic doses.
Does Glucosamine + Chondroitin need a prescription?
Glucosamine + Chondroitin is available over the counter. Even so, you should consult your veterinarian before giving any medication to your pet.

References

References

Textbooks & handbooks

  • Plumb, D.C. Plumb's Veterinary Drug Handbook. 10th ed., Wiley-Blackwell, 2023.
  • Vail, D.M., Thamm, D.H., & Liptak, J.M. (eds.). Withrow & MacEwen's Small Animal Clinical Oncology. 6th ed., Saunders/Elsevier, 2020.
  • Riviere, J.E., & Papich, M.G. (eds.). Veterinary Pharmacology and Therapeutics. 10th ed., Wiley-Blackwell, 2018.
  • National Research Council. Nutrient Requirements of Dogs and Cats. National Academies Press, Washington DC, 2006.
  • The Merck Veterinary Manual. Merck & Co., Online edition. https://www.merckvetmanual.com/

Clinical guidelines & consensus

  • Fletcher, D.J., Boller, M., Brainard, B.M., et al. "RECOVER Evidence and Knowledge Gap Analysis on Veterinary CPR." Journal of Veterinary Emergency and Critical Care, 2012;22(S1):S102–S131.
  • American Animal Hospital Association. 2018 AAHA Diabetes Management Guidelines for Dogs and Cats. AAHA Press.

Journals & peer-reviewed studies

  • Hogan, D.F., Fox, P.R., Jacob, K., et al. "Secondary prevention of cardiogenic arterial thromboembolism in the cat: The FAT CAT study." Journal of Veterinary Cardiology, 2015;17(Suppl 1):S306–S317.
  • Boswood, A., Häggström, J., Gordon, S.G., et al. "Effect of Pimobendan in Dogs with Preclinical Myxomatous Mitral Valve Disease and Cardiomegaly: The EPIC Study — A Randomized Clinical Trial." Journal of Veterinary Internal Medicine, 2016;30(6):1765–1779.
  • ASPCA Animal Poison Control Center. Toxicology and Poison Management Guidelines. American Society for the Prevention of Cruelty to Animals. https://www.aspca.org/pet-care/animal-poison-control

Regulatory & approvals

  • Central Drugs Standard Control Organisation (CDSCO), Government of India. Veterinary Drug Approval Registry, 1969–2026. Directorate General of Health Services. https://cdsco.gov.in/

Databases

  • Washington State University, College of Veterinary Medicine. Veterinary Clinical Pharmacology Laboratory (VCPL) — MDR1 Multidrug Sensitivity Database. https://vcpl.vetmed.wsu.edu/
Educational reference only
This information is provided for educational purposes and is not a substitute for professional veterinary advice, diagnosis, or treatment. Always consult a qualified veterinarian before administering any medication to your pet. Find a vet near you →